Deutsche Bank (ETR:DBKGn) initiated coverage on Denali Therapeutics Inc. (NASDAQ: NASDAQ:DNLI) with a Buy rating and set a price target of $31.00. The new assessment comes as Denali's shares are seen ...

Launched in 2018, the Morningstar Minority Empowerment Index highlights companies that demonstrate a strong commitment to ...

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

A new study led by Western researchers found frequent treatment with intranasal oxytocin – a hormone in the brain associated with empathy – offers promise for addressing a key symptom among patients ...

What's New for 2025? Adaptive cruise control with trailering assist, previously standard on the 2024 AT4X and Denali Ultimate trim levels, now comes on the AT4 and Denali trims as well.

The biotech sector in 2025 presents a landscape brimming with both opportunities and challenges. The industry is being shaped by a confluence of factors, all of which are driving exciting innovations ...

Alaska Native leaders, as well as state politicians, object that the order undoes years of work with the federal government to establish Denali as the rightful name. "Located on the traditional ...